Found: 77
Select item for more details and to access through your institution.
Resources-Stratified Guidelines for Classical Hodgkin Lymphoma.
- Published in:
- International Journal of Environmental Research & Public Health, 2020, v. 17, n. 5, p. 1783, doi. 10.3390/ijerph17051783
- By:
- Publication type:
- Article
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-Term Response and Remission with Pixantrone in Patients with Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma: Post-Hoc Analysis of the Multicenter, Open-Label, Randomized PIX301 Trial.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 6, p. 527, doi. 10.1007/s40261-018-0635-3
- By:
- Publication type:
- Article
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- clinical trial
The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project.
- Published in:
- Oncologist, 2017, v. 22, n. 12, p. 1415, doi. 10.1634/theoncologist.2017-0177
- By:
- Publication type:
- Article
Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 36, doi. 10.1002/cam4.939
- By:
- Publication type:
- Article
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 11, p. 1096, doi. 10.1002/ajh.24492
- By:
- Publication type:
- Article
Monotherapy with pixantrone in histologically confirmed relapsed or refractory aggressive B-cell non-Hodgkin lymphoma: post-hoc analyses from a phase III trial.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 5, p. 692, doi. 10.1111/bjh.14101
- By:
- Publication type:
- Article
A phase II, single-arm, multicentre study of coltuximab ravtansine ( SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 5, p. 722, doi. 10.1111/bjh.13992
- By:
- Publication type:
- Article
Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0243-8
- By:
- Publication type:
- Article
Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysis.
- Published in:
- Experimental Hematology & Oncology, 2015, v. 4, n. 1, p. 1, doi. 10.1186/s40164-015-0006-1
- By:
- Publication type:
- Article
Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemia.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 2, p. 423, doi. 10.1007/s10637-015-0206-x
- By:
- Publication type:
- Article
Population pharmacokinetics of ofatumumab in patients with chronic lymphocytic leukemia, follicular lymphoma, and rheumatoid arthritis.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 7, p. 818, doi. 10.1002/jcph.268
- By:
- Publication type:
- Article
Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 5, p. 659, doi. 10.1111/bjh.12675
- By:
- Publication type:
- Article
Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses.
- Published in:
- Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 1, doi. 10.1186/1756-8722-7-11
- By:
- Publication type:
- Article
Impact of BMI and Gender on Outcomes in DLBCL Patients Treated with R-CHOP: A Pooled Study from the LYSA.
- Published in:
- Lymphoma (2090309X), 2014, p. 1, doi. 10.1155/2014/205215
- By:
- Publication type:
- Article
A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 3, p. 334, doi. 10.1111/bjh.12537
- By:
- Publication type:
- Article
A Randomized Study of Interferon α-2b Versus No Treatment as Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Patients With Relapsed Lymphoma.
- Published in:
- Oncologist, 2013, v. 18, n. 11, p. 1189, doi. 10.1634/theoncologist.2013-0223
- By:
- Publication type:
- Article
Clinical Efficacy and Management of Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 4, p. 351, doi. 10.1016/j.clml.2013.04.003
- By:
- Publication type:
- Article
Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-45
- By:
- Publication type:
- Article
Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.
- Published in:
- Histopathology, 2013, v. 62, n. 6, p. 876, doi. 10.1111/his.12092
- By:
- Publication type:
- Article
Pretreatment Levels of Vascular Endothelial Growth Factor in Plasma Predict a Complete Remission Rate and Time to Relapse or Progression in Patients with Diffuse Large B-Cell Lymphoma.
- Published in:
- Archivum Immunologiae & Therapiae Experimentalis, 2013, v. 61, n. 2, p. 165, doi. 10.1007/s00005-012-0215-9
- By:
- Publication type:
- Article
When Can R-CHOP Not Be Used in an Elderly Patient?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 2, p. 146
- By:
- Publication type:
- Article
The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: A study of 826 cases from the International Peripheral T-cell Lymphoma Project.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 8, p. 790, doi. 10.1002/ajh.23205
- By:
- Publication type:
- Article
Pralatrexate Is an Effective Treatment for Relapsed or Refractory Transformed Mycosis Fungoides: A Subgroup Efficacy Analysis From the PROPEL Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 4, p. 238, doi. 10.1016/j.clml.2012.01.010
- By:
- Publication type:
- Article
Ten-year relative survival and causes of death in elderly patients treated with R-CHOP or CHOP in the GELA LNH-985 trial.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Lymphoma and Leukemia of the Nervous System.
- Published in:
- 2012
- By:
- Publication type:
- Book Review
Splenic Marginal Zone Lymphoma: Current Knowledge and Future Directions.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 2, p. 194
- By:
- Publication type:
- Article
MicroRNA expression profile in splenic marginal zone lymphoma.
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 2, p. 279, doi. 10.1111/j.1365-2141.2011.08848.x
- By:
- Publication type:
- Article
Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2012, v. 5, n. 1, p. 27, doi. 10.1186/1756-8722-5-27
- By:
- Publication type:
- Article
Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial.
- Published in:
- Journal of Hematology & Oncology, 2012, v. 5, n. 1, p. 67, doi. 10.1186/1756-8722-5-67
- By:
- Publication type:
- Article
Nodal Marginal Zone B-Cell Lymphoma: A Diagnostic and Therapeutic Dilemma.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 1, p. 92
- By:
- Publication type:
- Article
MALT Lymphomas: Pathogenesis Can Drive Treatment.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 12, p. 1134
- By:
- Publication type:
- Article
90Y Ibritumomab Tiuxetan (Zevalin) Combined With BEAM (Z -BEAM) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed or Refractory Low-grade CD20-positive B-cell Lymphoma. A GELA Phase II Prospective Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 212, doi. 10.1016/j.clml.2011.03.007
- By:
- Publication type:
- Article
Treatment of Post-transplant Lymphomas.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 10, p. 950
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1–2 study.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 1, p. 58, doi. 10.1111/j.1365-2141.2010.08193.x
- By:
- Publication type:
- Article
Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity?
- Published in:
- 2010
- By:
- Publication type:
- Letter
Targeted treatment and new agents in diffuse large B cell lymphoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 4, p. 578, doi. 10.1111/j.1365-2141.2010.08143.x
- By:
- Publication type:
- Article
Plasma TNF-α and IL-10 Level-Based Prognostic Model Predicts Outcome of Patients with Diffuse Large B-Cell Lymphoma in Different Risk Groups Defined by the International Prognostic Index.
- Published in:
- Archivum Immunologiae & Therapiae Experimentalis, 2010, v. 58, n. 2, p. 131, doi. 10.1007/s00005-010-0066-1
- By:
- Publication type:
- Article
Nodular, Lymphocyte-Predominant Hodgkin Lymphoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 3, p. 631, doi. 10.1002/cncr.24819
- By:
- Publication type:
- Article
Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) Guidelines on the Use of Granulocyte Colony-Stimulating Factor (G-CSF) for Lymphoma Care.
- Published in:
- Clinical Drug Investigation, 2009, v. 29, n. 8, p. 491, doi. 10.2165/00044011-200929080-00001
- By:
- Publication type:
- Article
Epstein-Barr Virus–Induced Lymphoproliferative Disorder After Rituximab Combined with CHOP Therapy.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 6, p. 356
- By:
- Publication type:
- Article
The Challenges of Hodgkin Lymphoma in the Elderly.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 12, p. 1388
- By:
- Publication type:
- Article
Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 5, p. 855, doi. 10.1007/s00280-007-0543-3
- By:
- Publication type:
- Article
Unanswered Questions in Follicular Lymphoma.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 1, p. 33
- By:
- Publication type:
- Article
Strategies for Improving Outcomes with 14-Day Anthracycline- Based Regimens in Patients with Aggressive Lymphomas.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 8, p. S50
- By:
- Publication type:
- Article
Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.
- Published in:
- Genes, Chromosomes & Cancer, 2007, v. 46, n. 5, p. 500, doi. 10.1002/gcc.20436
- By:
- Publication type:
- Article
Treatment of Non-Hodgkin's Lymphoma: A Look over the Past Decade.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, p. s7
- By:
- Publication type:
- Article
Management of marginal zone lymphomas.
- Published in:
- 2006
- By:
- Publication type:
- journal article